logo
Weather page
GET THE APP
ePaper
google_play
app_store
  • Login
  • E-Edition
  • Sports
  • Obituaries
  • News
  • Opinion
  • Classifieds
    • Place an Ad
    • All Listings
    • Jobs
  • SPECIAL SECTIONS
  • GALLERY
  • CONTESTS
  • LIFESTYLE/ENTERTAINMENT
  • GAMES
  • Allegany County Source
    • News
      • local
      • state
      • nation/world
    • Sports
      • local
      • college
      • State
      • national
    • Obituaries
    • Opinion
      • News
        • local
        • state
        • nation/world
      • Sports
        • local
        • college
        • State
        • national
      • Obituaries
      • Opinion
    logo
    • Classifieds
      • Place an Ad
      • All Listings
      • Jobs
    • E-Edition
    • Subscribe
    • Login
      • Classifieds
        • Place an Ad
        • All Listings
        • Jobs
      • E-Edition
      • Subscribe
      • Login
    Home

    Olean Times Herald

    Posts
    Stealth BioTherapeutics to Present New Bevemipretide Data at ARVO Annual Meeting
    Press Releases
    Stealth BioTherapeutics to Present New Bevemipretide Data at ARVO Annual Meeting
    STEALTH BIOTHERAPEUTICS INC. 
    April 24, 2025
    NEEDHAM, Mass. , April 24, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focu...
    Read More...
    {"website":"Website"}
    Stealth BioTherapeutics Announces Achievement of 50% Enrollment Target in Phase 3 ReNEW Study of Elamipretide in Patients with Dry Age-Related Macular Degeneration
    Press Releases
    Stealth BioTherapeutics Announces Achievement of 50% Enrollment Target in Phase 3 ReNEW Study of Elamipretide in Patients with Dry Age-Related Macular Degeneration
    STEALTH BIOTHERAPEUTICS INC. 
    March 13, 2025
    NEEDHAM, Mass. , March 13, 2025 /PRNewswire/ --Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biopharmaceutical company f...
    Read More...
    {"website":"Website"}
    Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
    Press Releases
    Stealth BioTherapeutics Announces PDUFA Action Date Extension for Elamipretide to Treat Patients with Barth Syndrome
    STEALTH BIOTHERAPEUTICS INC. 
    January 23, 2025
    – New PDUFA Action Date ofApril 29, 2025, Allows FDA Additional Time to Complete Review – – Follows Positive FDA Advisory Committee Meeting Vote Concl...
    Read More...
    {"website":"Website"}
    Local & Social

    Get in touch with Olean Times Herald

    Submit Content
    Send a Letter to the Editor Place Wedding Announcement Place Engagement Announcement
    Advertise
    Place Birth Announcement Place Anniversary Announcement Place Obituary
    Subscribe
    Start a Subscription e-Edition Contact Us
    Illinois Hancock Journal-Pilot Iroquois Times-Republic Journal-Republican The News-Gazette
    Indiana Fountain Co. Neighbor Herald Journal KV Post News Newton Co. Enterprise Rensselaer Republican Review-Republican
    Iowa Atlantic News Telegraph Audubon Advocate-Journal Barr's Post Card News Burlington Hawk Eye Collector's Journal Fayette County Union Ft. Madison Daily Democrat Independence Bulletin-Journal Keokuk Daily Gate City Oelwein Daily Register Vinton Newspapers Waverly Newspapers
    Michigan Iosco County News-Herald Ludington Daily News Oceana's Herald-Journal Oscoda Press White Lake Beacon New York Finger Lakes Times Olean Times Herald Salamanca Press
    Pennsylvania Bradford Era Clearfield Progress Courier Express Free Press Courier Jeffersonian Democrat Leader Vindicator Potter Leader-Enterprise The Wellsboro Gazette
    © Copyright Olean Times Herald 639 Norton Drive, Olean, NY 14760  | Terms of Use  | Privacy Policy
    Powered by TECNAVIA